@article{UBHD-69351229,
  author={Jaramillo Segura, Sonia and Scherer, Michael and Szu-Tu, Chelsea and Beneyto-Calabuig, Sergi and M{\"u}ller-Tidow, Carsten and Schlenk, Richard Friedrich and Hundemer, Michael and Velten, Lars and Pabst, Caroline},
  title={Late-onset NPM1 mutation in a MYC-amplified relapsed/refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib},
  year={2024},
  pages={3811-3815},
  language={eng},
  issn={1592-8721},
  volume={109},
  number={11 vom: Nov.},
  note={Gesehen am 02.06.2025},
  journal={Haematologica},
  doi={10.3324/haematol.2023.284922},
}
@incollection{UBHD-68495200,
  author={Jaramillo Segura, Sonia and Schubert, Maria-Luisa},
  title={Molekulare Charakterisierung der AML},
  year={2020},
  pages={17-32},
  language={ger},
  isbn={978-3-11-059979-4 and 978-3-11-059855-1},
  booktitle={Myeloische Neoplasien},
}
@article{UBHD-68782737,
  author={Jaramillo Segura, Sonia and Schlenk, Richard Friedrich},
  title={Post-induction treatment for acute myeloid leukemia: something change?},
  year={2021},
  pages={1-10$t10},
  language={eng},
  issn={1534-6269},
  volume={23},
  note={Gesehen am 23.09.2021},
  journal={Current oncology reports},
  doi={10.1007/s11912-021-01092-0},
  url={https://doi.org/10.1007/s11912-021-01092-0},
  library={UB},
}
@article{UBHD-69143071,
  author={Jaramillo Segura, Sonia and Le Cornet, Lucian and Kratzmann, Markus and Krisam, Johannes and G{\"o}rner, Martin and H{\"a}nel, Mathias and R{\"o}llig, Christoph and Wass, Maxi and Scholl, Sebastian and Ringhoffer, Mark and Reichart, Alexander and Steffen, Bj{\"o}rn and Kayser, Sabine and Mikesch, Jan-Henrik and Schaefer-Eckart, Kerstin and Schubert, J{\"o}rg and Geer, Thomas and Martin, Sonja and Kieser, Meinhard and Sauer, Tim and Kriegsmann, Katharina and Hundemer, Michael and Serve, Hubert and Bornh{\"a}user, Martin and M{\"u}ller-Tidow, Carsten and Schlenk, Richard Friedrich},
  title={Q-HAM},
  subtitle={a multicenter upfront randomized phase II trial of quizartinib and high-dose Ara-C plus mitoxantrone in relapsed/refractory AML with FLT3-ITD},
  year={2023},
  pages={1-15},
  language={eng},
  issn={1468-6694 and 1745-6215},
  volume={24},
  number={Artikel-ID 591},
  note={Ver{\"o}ffentlicht: 15. September 2023 ; Gesehen am 15.11.2023},
  journal={Trials},
  doi={10.1186/s13063-023-07421-x},
}
@article{UBHD-68826925,
  author={Jaramillo Segura, Sonia and Krisam, Johannes and Le Cornet, Lucian and Kratzmann, Markus and Baumann, Lukas and Sauer, Tim and Crysandt, Martina and Rank, Andreas and Behringer, Dirk and Teichmann, Lino and G{\"o}rner, Martin and Trappe, Ralf-Ulrich and R{\"o}llig, Christoph and Krause, Stefan and Hanoun, Maher and Hopfer, Olaf and Held, Gerhard and Buske, Sebastian and Fransecky, Lars and Kayser, Sabine and Schliemann, Christoph and Schaefer-Eckart, Kerstin and Al-Fareh, Yousef and Schubert, J{\"o}rg and Geer, Thomas and Kaufmann, Martin and Brecht, Arne and Niemann, Dirk and Kieser, Meinhard and Bornh{\"a}user, Martin and Platzbecker, Uwe and Serve, Hubert and Baldus, Claudia D. and M{\"u}ller-Tidow, Carsten and Schlenk, Richard Friedrich},
  title={Rationale and design of the 2 by 2 factorial design GnG-trial},
  subtitle={a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AML},
  year={2021},
  pages={1-13},
  language={eng},
  issn={1468-6694 and 1745-6215},
  volume={22},
  number={Artikel-ID 765},
  note={Gesehen am 16.12.2021},
  journal={Trials},
  doi={10.1186/s13063-021-05703-w},
  url={https://doi.org/10.1186/s13063-021-05703-w},
  library={UB},
}
@article{UBHD-68777198,
  author={Jaramillo Segura, Sonia and Hennemann, Hannah Mai and Horak, Peter and Teleanu, Maria-Veronica and Heilig, Christoph E. and Hutter, Barbara and Stenzinger, Albrecht and Glimm, Hanno and Goeppert, Benjamin and M{\"u}ller-Tidow, Carsten and Fr{\"o}hling, Stefan and Sch{\"o}nland, Stefan and Schlenk, Richard Friedrich},
  title={Ruxolitinib is effective in the treatment of a patient with refractory T-ALL},
  year={2021},
  pages={139-142},
  language={eng},
  issn={2688-6146},
  volume={2},
  number={1},
  note={First published: 04 December 2020 ; Gesehen am 07.09.2021},
  journal={eJHaem},
  doi={10.1002/jha2.143},
  url={https://doi.org/10.1002/jha2.143},
  library={UB},
}
@article{UBHD-69052552,
  author={Jaramillo Segura, Sonia and Schlenk, Richard Friedrich},
  title={Update on current treatments for adult acute myeloid leukemia},
  subtitle={to treat acute myeloid leukemia intensively or non-intensively? That is the question},
  year={2023},
  pages={342-352},
  language={eng},
  issn={1592-8721},
  volume={108},
  number={2 vom: Feb.},
  note={Gesehen am 16.03.2023},
  journal={Haematologica},
  doi={10.3324/haematol.2022.280802},
}
@incollection{UBHD-68478834,
  author={Schlenk, Richard Friedrich and Jaramillo Segura, Sonia and M{\"u}ller-Tidow, Carsten},
  title={What's new in consolidation therapy in AML?},
  year={2019},
  pages={96-101},
  language={eng},
  note={Available online 29 August 2018 ; Gesehen am 21.01.2020},
  booktitle={ScienceDirect},
  doi={10.1053/j.seminhematol.2018.08.005},
}